HK$1.62 9906.HK Honliv Healthcare HKSE after hours 26 Feb 2026: Oversold bounce
We note 9906.HK stock trading at HKD 1.62 in after hours on 26 Feb 2026, down modestly from the prior close. This price sits near the recent low band while volume remains light at 2,000 shares, creating a setup for an oversold bounce trade. We assess technicals, valuation, and near-term catalysts to judge whether a short-term rebound is likely for Honliv Healthcare Management Group Company Limited (9906.HK) on the HKSE.
Price action and immediate setup for 9906.HK stock
Honliv Healthcare (9906.HK) closed the regular session at HKD 1.62 and is trading after hours on 26 Feb 2026. The stock is below its 50-day average of HKD 1.68 but above its 200-day average of HKD 1.58, a mixed short-term technical picture. Daily volume is 2,000 versus an average volume of 1,254, so any bounce could be fragile without follow-through.
Technical indicators point to oversold bounce opportunity
Momentum indicators register weakness, with Williams %R at -76.47 and CCI at -95.02, which supports an oversold reading. The MACD histogram is slightly negative and ROC shows -7.43%, implying downside pressure has eased. Traders looking for an oversold bounce may watch for a reclaim of HKD 1.68 (50-day MA) and a volume uptick above 3,000 to confirm a short-term reversal.
Fundamentals and valuation snapshot for 9906.HK stock
Honliv Healthcare operates a 1,500-bed hospital network and related services in Mainland China. Key fundamentals show EPS HKD 0.02 and a price-to-book of 1.39, with market cap near HKD 972,000,000.00. Trailing P/E is elevated at 73.99, reflecting thin earnings and limited margin. Cash per share is HKD 0.53 and current ratio is 1.03, giving a modest liquidity cushion.
Meyka AI rates 9906.HK with a score out of 100
Meyka AI rates 9906.HK with a score out of 100. Score: 67.36 out of 100 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The company scores well on price-to-book and free cash flow yield, but the high P/E and lower return metrics weigh on the grade. These grades are informational and not financial advice.
Meyka AI’s forecast and price projection
Meyka AI’s forecast model projects a monthly price of HKD 1.28, a quarterly price of HKD 1.19, and a yearly price of HKD 1.19. Compared with the current HKD 1.62, the model implies downside of about -20.99% on the monthly view and -26.54% on the quarterly view. Forecasts are model-based projections and not guarantees.
Catalysts, sector context and trade risks
Catalysts that could prompt an oversold bounce include improved patient volumes, a positive earnings surprise, or stronger sector flows into healthcare stocks in Hong Kong. The healthcare sector average P/E is 27.53, so Honliv trades at a premium on earnings. Key risks include weak margin expansion, low liquidity, and earnings volatility. Keep position sizing tight given average daily volume near 1,254 shares.
Final Thoughts
Key takeaways for 9906.HK stock: the market shows an oversold technical profile on 26 Feb 2026 with price at HKD 1.62 and low trading volume. Fundamentals show modest cash and book value support, but a high trailing P/E of 73.99 and low EPS of HKD 0.02 increase valuation risk. Meyka AI’s forecast model projects a yearly price of HKD 1.19, implying roughly -26.34% downside versus today. For traders focused on an oversold bounce, a clear entry condition is a rebound above HKD 1.68 with rising volume and sector breadth improvement. For investors, the Meyka grade of B (67.36) suggests monitor and hold rather than add aggressively. All forecasts are model-based projections and not guarantees. We use this data to shape a disciplined approach to short-term bounce trades and longer-term position sizing.
FAQs
What is the current price and session for 9906.HK stock?
On 26 Feb 2026 after hours, 9906.HK stock is trading at HKD 1.62. The day range was HKD 1.62 to HKD 1.62 with volume of 2,000 shares.
What does Meyka AI forecast for 9906.HK stock?
Meyka AI’s forecast model projects monthly HKD 1.28, quarterly HKD 1.19, and yearly HKD 1.19 for 9906.HK stock. These are model projections and not guarantees.
What technical trigger should traders use for an oversold bounce?
For an oversold bounce in 9906.HK stock, look for a reclaim above the 50-day MA HKD 1.68 with volume exceeding 3,000 shares and supportive momentum readings.
What are main risks for 9906.HK stock investors?
Main risks include high P/E at 73.99, low liquidity, earnings volatility, and sector headwinds. Investors should size positions conservatively while monitoring company updates.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.